{"id":"W2089796211","doi":"10.3111/13696998.2013.802239","title":"Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Fingolimod; Multiple sclerosis; Randomized controlled trial; Natalizumab; Physical therapy; Disease; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007786145,0.002925956,0.005925758,0.0009688681,0.001523015,0.001651259,0.001817225,0.004171128,0.01009825],"category_scores_gemma":[0.005407918,0.001272202,0.001787744,0.001046543,0.003780234,0.002223101,0.0009166626,0.005329824,0.001965603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001568576,"about_ca_system_score_gemma":0.006099533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001530913,"about_ca_topic_score_gemma":0.003086803,"domain_scores_codex":[0.9956278,0.002339404,0.0002410933,0.0006553862,0.0005647364,0.0005716981],"domain_scores_gemma":[0.9945388,0.001421191,0.0009780013,0.0005786025,0.0006923384,0.001790952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9679925,0.02356139,0.0008610336,0.0002206165,0.0003266767,0.00003886365,0.00003370677,0.000169223,0.001380762,0.0001158795,0.000641671,0.004657572],"study_design_scores_gemma":[0.9398732,0.0583149,0.0007989994,0.000009403854,0.0001071888,0.00001198039,0.000007606255,0.0001402826,0.0001781724,0.00008859697,0.0004603255,0.000009311516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.8831321,0.002335512,0.0024884,0.00139768,0.001407635,0.09961335,0.005214878,0.000285904,0.004124451],"genre_scores_gemma":[0.8431445,0.001710774,0.008837585,0.003538933,0.002319545,0.1299994,0.003443958,0.00007293341,0.006932405],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01009825,"threshold_uncertainty_score":0.04117751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1737127941850504,"score_gpt":0.369475554435499,"score_spread":0.1957627602504486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}